IPSOS: A Phase III, Global, Multicentre, Open-Label, Randomised, Controlled Study of First-Line Atezolizumab Versus Single-Agent Chemotherapy in Patients with Non-Small Cell Lung Cancer Ineligible for Treatment with a Platinum-Containing Regimen

Siow Ming Lee, Christian Klaus Jochen Schulz, Kumar Prabhash et al. · SSRN Electronic Journal · 2022

Cited by 2 works. doi:10.2139/ssrn.4307691

Authors